Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
October 8, 2018
The article highlights critical challenges within the healthcare sector, with a significant focus on the role of AI for healthcare. FDNA, a biotechnology company utilizing AI, is transforming diagnostic accuracy and efficiency by analyzing facial patterns to identify rare genetic disorders. This innovative application of AI is addressing the pressing need for faster and more precise diagnoses, emphasizing the potential of AI to revolutionize healthcare practices. The article highlights the importance of integrating advanced AI decision support tools to enhance patient outcomes and streamline medical processes.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…